From Pilots to Platforms: Where AI Maturity Really Shows Up

A lot of biopharma teams are past the “What can GenAI do?” stage.

They’ve run small pilots: summarizing research, generating SQL, or building assistants on top of proprietary datasets. And some of these experiments are genuinely useful. But most remain siloed. Interesting, not integrated.

This is where the maturity gap shows up.

To move forward, it’s not just about model performance. You need:

– A real data foundation (quality, context, lineage),
– Governance and compliance guardrails,
– MLOps pipelines that connect to business logic,
– And clarity on where this output plugs into decisions.

We’ve all seen this firsthand: traditional analytics and GenAI don’t compete — they amplify each other when orchestrated well. That’s when AI shifts from an assistant to a co-pilot.

But to get there, we need more than experimentation. We need integration. The AI model is often ~15% of the effort. The other 85%? That’s architecture, process, and trust.

#AIinHealthcare #AnalyticsEnablement #DataStrategy #CommercialAnalytics #RWE #EnterpriseAI #GenAI #AIMaturity